Advertisement

Topics

Alpha Source, Inc. Company Profile

10:25 EDT 21st September 2018 | BioPortfolio

Alpha Source, Inc. is a leading provider of medical equipment and supplies, specializing in medical lighting and batteries.

Location

12104 W. Carmen Avenue
Milwaukee
Wisconsin
53225
United States of America


News Articles [245 Associated News Articles listed on BioPortfolio]

Mass. agency OKs Alpha Tau's cancer-zapping device for use in trials

The Massachusetts Radiation Control Program has granted Israel-based Alpha Tau Medical a Sealed Source and Device approval fo -More- 

Radiation cancer therapy co Alpha Tau Medical raises $29m

Alpha DaRT enables the first alpha-radiation-based cancer treatment for various types of solid tumors.

BU medical student receives student fellowship from Alpha Omega Alpha

(Boston University School of Medicine) Melissa Chua, a fourth-year medical student at Boston University School of Medicine (BUSM), has received the Alpha Omega Alpha (AOA) Carolyn L. Kuckein Student R...

Ultralow Alpha MetalNorth America Market Status and Trend Report 20132023 [Report Updated: 12022018] Prices from USD $3480

Report SummaryUltralow Alpha MetalNorth America Market Status and Trend Report 20132023 offers a comprehensive analysis on Ultralow Alpha Metal industry, standing on the readers' perspective, deliveri...

Israeli radiation therapy firm Alpha Tau raises $29 million

Alpha Tau Medical, an Israeli developer of alpha radiation cancer therapy, said on Wednesday it raised $29 million in a private financing round led by private equity firm Shavit Capital.

Alpha Tau Medical gets $29M boost

A round of financing has brought in $29 million for Israel-based Alpha Tau Medical, which is developing technology called Alp -More- 

Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the Company recentl...

Ultralow Alpha MetalGlobal Market Status Trend Report 20132023 Top 20 Countries Data [Report Updated: 12022018] Prices from USD $3680

Report SummaryUltralow Alpha MetalGlobal Market Status Trend Report 20132023 Top 20 Countries Data offers a comprehensive analysis on Ultralow Alpha Metal industry, standing on the readers' perspecti...

PubMed Articles [1004 Associated PubMed Articles listed on BioPortfolio]

Detection of alpha radionuclides in air from patients during Ra-223 alpha radionuclide therapy.

Ra-223 has recently been introduced to alpha radionuclide therapy. According to the decay scheme of Ra-223, an inert gas, Rn-219 is released from patients during alpha radionuclide therapy and its dau...

Basophil Activation Test Differentiates Between Patients with Alpha-Gal Syndrome and Asymptomatic Alpha-Gal Sensitization.

The alpha-gal syndrome is characterized by the presence of sIgE antibodies to alpha-gal and delayed type I allergic reaction to the carbohydrate galactose-alpha-1,3-galactose (alpha-gal) after consump...

Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation.

Anti-aging strategies utilizing stem cells are in the forefront. Alpha and beta defensins are natural immune peptides that have been shown to activate an LGR6-positive stem cell locus in the hair foll...

Alignment of alpha-band desynchronization with syntactic structure predicts successful sentence comprehension.

Sentence comprehension requires the encoding of phrases and their relationships into working memory. To date, despite the importance of neural oscillations in language comprehension, the neural-oscill...

Longterm Homecare Augmentation Program in Alpha-1-Antitrypsin Deficient Patients.

Augmentation with human alpha-1 proteinase inhibitor is the only specific treatment for Alpha-1-Antitrypsin Deficiency (AATD), a rare genetic disease with symptoms of progressive COPD.

Clinical Trials [1542 Associated Clinical Trials listed on BioPortfolio]

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

The purpose of the study is to test safety and efficacy of different doses of thymosin alpha 1 (1.6 mg, 3.2 mg, and 6.4 mg) in combination with dacarbazine and with or without Interferon a...

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Alpha MSH in Ocular Disease

The purpose of this study is gain a better understanding of a molecule called alpha melanocyte stimulating hormone (alpha MSH) and its potential role in your retinal disease. Alpha MSH has...

Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis

This is a single-center, open-label, multiple-dose study of the efficacy and long-term safety of Lamazym for the treatment of patients with alpha-mannosidosis.

Companies [692 Associated Companies listed on BioPortfolio]

Alpha Source, Inc.

Alpha Source, Inc. is a leading provider of medical equipment and supplies, specializing in medical lighting and batteries.

Alpha-1 Foundation

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

The Alpha-1 Project

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures ...

Alpha-1 Foundation and Foundation for Sarcoidosis Research

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

Alpha-Stim

Alpha-Stim is an industry leader in cranial electrotherapy stimulation (CES) devices, providing treatment for anxiety, depression, insomnia and pain, without the side effects comm...

More Information about "Alpha Source, Inc." on BioPortfolio

We have published hundreds of Alpha Source, Inc. news stories on BioPortfolio along with dozens of Alpha Source, Inc. Clinical Trials and PubMed Articles about Alpha Source, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alpha Source, Inc. Companies in our database. You can also find out about relevant Alpha Source, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record